Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Vita Life Sciences Limited ( (AU:VLS) ) is now available.
Vita Life Sciences Limited has cancelled 11,404 ordinary fully paid shares following execution of an on-market buy-back, as disclosed in its Appendix 3H notification to the ASX dated March 25, 2026. The reduction in issued capital marginally increases the ownership percentage of remaining shareholders and reflects the company’s ongoing use of buy-backs as a capital management tool, potentially signaling confidence in its valuation and balance sheet strength.
The most recent analyst rating on (AU:VLS) stock is a Buy with a A$3.00 price target. To see the full list of analyst forecasts on Vita Life Sciences Limited stock, see the AU:VLS Stock Forecast page.
More about Vita Life Sciences Limited
Vita Life Sciences Limited is an Australian-listed company in the life sciences sector, trading on the ASX under the code VLS. The company’s issued capital includes ordinary fully paid shares, and it actively manages its capital structure through mechanisms such as on-market share buy-backs.
Average Trading Volume: 15,075
Technical Sentiment Signal: Buy
Current Market Cap: A$137.3M
For a thorough assessment of VLS stock, go to TipRanks’ Stock Analysis page.